FDA's 2005 NME Approvals: Agency Lags At Third Quarter Mark?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves just over half as many new molecular entities in first three quarters of 2005 as in the same period of 2004; BLA tally is well ahead of full year 2004.